e-learning
resources
Barcelona 2013
Monday, 09.09.2013
COPD and tobacco management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obscure chronic obstructive pulmonary disease in tobacco smokers having ischemic heart disease
A. Naveed, T. Mahmud, N. H. Bokhari, M. Aasim (Lahore, Pakistan)
Source:
Annual Congress 2013 –COPD and tobacco management
Session:
COPD and tobacco management
Session type:
Poster Discussion
Number:
2082
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Naveed, T. Mahmud, N. H. Bokhari, M. Aasim (Lahore, Pakistan). Obscure chronic obstructive pulmonary disease in tobacco smokers having ischemic heart disease. Eur Respir J 2013; 42: Suppl. 57, 2082
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
How to screen chronic obstructive pulmonary disease in general practice?
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Smoking abstinence in patients with chronic airway obstructive disease
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006
Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Smoking cessation in patients with respiratory diseases
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006
The questionnaire chronic obstructive pulmonary disease-population screener (COPD-PS) as a screening of the chronic obstructive pulmorary disease (COPD) in a quitting smoke medical practice
Source: International Congress 2016 – Smoking cessation strategies
Year: 2016
Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Influence of tobacco smoking on respiratory muscles function in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 247s
Year: 2006
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Epidemiology of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 17: 982-994
Year: 2001
Chronic obstructive pulmonary disease in smokers with asthma
Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission
Year: 2011
Overview of smoking-related disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Detection of asthma and chronic obstructive pulmonary disease in primary care
Source: Eur Respir J 2003; 21: 16S-22S
Year: 2003
Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – Passive smoking and epidemiology
Year: 2017
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Tobacco smoking habits by patients with chronic obstructive pulmonary disease (COPD) and their impact on number of hospitalizations
Source: Eur Respir J 2007; 30: Suppl. 51, 169s
Year: 2007
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept